Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine
Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important problem of lamivudine treatment is the emergence o...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Qom University of Medical Sciences
2011-06-01
|
| Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
| Subjects: | |
| Online Access: | http://journal.muq.ac.ir/article-1-80-en.html |
| _version_ | 1818416784027418624 |
|---|---|
| author | R Rafiei Tabatabaei R Ehsani A Pouryasin A Soudbakhsh H Sharafi |
| author_facet | R Rafiei Tabatabaei R Ehsani A Pouryasin A Soudbakhsh H Sharafi |
| author_sort | R Rafiei Tabatabaei |
| collection | DOAJ |
| description | Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important problem of lamivudine treatment is the emergence of lamivudine resistance strains with amino acid substitution in the YMDD motif of the DNA polymerase during the treatment. The aim of this study was to evaluate the frequency of YMDD motif mutations in chronic hepatitis B patients treated with lamivudine. Methods: 56 chronic hepatitis B patients who had not previously received interferon and/or a nucleoside/nucleotide analogue, received lamivudine for a minimum of 6 months were examined in this study. HBV DNA was extracted from serum samples, and YMDD mutations in the HBV DNA polymerase gene was determined using PCR-direct sequencing. HBV DNA quantification was determined using real-time PCR. Results: 56 patients 39 (69.6%) male and 17 (30.4%) female with mean age of 34.12±) 13.6 (were evaluated. YMDD motif mutations were observed in 15 out of 56 patients (26.7%). 8 of these mutations (14.2%) were in the form of YIDD and the remaining 7 (12.5%) in YVDD form. Serine mutation at YMDD motif was not found in this study. Conclusion: YMDD motif mutations leading to lamivudine resistance is common in our chronic hepatitis B patients. Molecular diagnosis of YMDD motif mutations using methods such as direct DNA sequencing can detect upcoming viral resistance in chronic hepatitis B patients. |
| first_indexed | 2024-12-14T11:56:23Z |
| format | Article |
| id | doaj.art-a4d0180dc791475aa95be060bb21ac18 |
| institution | Directory Open Access Journal |
| issn | 1735-7799 2008-1375 |
| language | fas |
| last_indexed | 2024-12-14T11:56:23Z |
| publishDate | 2011-06-01 |
| publisher | Qom University of Medical Sciences |
| record_format | Article |
| series | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
| spelling | doaj.art-a4d0180dc791475aa95be060bb21ac182022-12-21T23:02:05ZfasQom University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum1735-77992008-13752011-06-01523944Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with LamivudineR Rafiei Tabatabaei0R Ehsani1A Pouryasin2A Soudbakhsh3H Sharafi4 Tehran North Branch Tehran North Branch Islamic Azad University, Arsanjan Branch Tehran University of Medical Sciences Tehran University of Medical Sciences Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important problem of lamivudine treatment is the emergence of lamivudine resistance strains with amino acid substitution in the YMDD motif of the DNA polymerase during the treatment. The aim of this study was to evaluate the frequency of YMDD motif mutations in chronic hepatitis B patients treated with lamivudine. Methods: 56 chronic hepatitis B patients who had not previously received interferon and/or a nucleoside/nucleotide analogue, received lamivudine for a minimum of 6 months were examined in this study. HBV DNA was extracted from serum samples, and YMDD mutations in the HBV DNA polymerase gene was determined using PCR-direct sequencing. HBV DNA quantification was determined using real-time PCR. Results: 56 patients 39 (69.6%) male and 17 (30.4%) female with mean age of 34.12±) 13.6 (were evaluated. YMDD motif mutations were observed in 15 out of 56 patients (26.7%). 8 of these mutations (14.2%) were in the form of YIDD and the remaining 7 (12.5%) in YVDD form. Serine mutation at YMDD motif was not found in this study. Conclusion: YMDD motif mutations leading to lamivudine resistance is common in our chronic hepatitis B patients. Molecular diagnosis of YMDD motif mutations using methods such as direct DNA sequencing can detect upcoming viral resistance in chronic hepatitis B patients.http://journal.muq.ac.ir/article-1-80-en.htmlhepatitis b viruschronic hepatitis blamivudineymdd motif mutations |
| spellingShingle | R Rafiei Tabatabaei R Ehsani A Pouryasin A Soudbakhsh H Sharafi Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum hepatitis b virus chronic hepatitis b lamivudine ymdd motif mutations |
| title | Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine |
| title_full | Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine |
| title_fullStr | Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine |
| title_full_unstemmed | Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine |
| title_short | Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine |
| title_sort | detection of the ymdd motif mutations rate in chronic hepatitis b patients treated with lamivudine |
| topic | hepatitis b virus chronic hepatitis b lamivudine ymdd motif mutations |
| url | http://journal.muq.ac.ir/article-1-80-en.html |
| work_keys_str_mv | AT rrafieitabatabaei detectionoftheymddmotifmutationsrateinchronichepatitisbpatientstreatedwithlamivudine AT rehsani detectionoftheymddmotifmutationsrateinchronichepatitisbpatientstreatedwithlamivudine AT apouryasin detectionoftheymddmotifmutationsrateinchronichepatitisbpatientstreatedwithlamivudine AT asoudbakhsh detectionoftheymddmotifmutationsrateinchronichepatitisbpatientstreatedwithlamivudine AT hsharafi detectionoftheymddmotifmutationsrateinchronichepatitisbpatientstreatedwithlamivudine |